BD to Demonstrate Expanded Vascular Access Offerings from Insertion to Removal during the 5th World Congress on Vascular Access (WoCoVA)

Visit BD Booth #9 and 10 to Learn how the Most Common Invasive Procedure doesn't Need to be One of the Most Complex 

COPENHAGEN, Denmark, June 20, 2018 /PRNewswire/ -- During the 5^th annual World Congress on Vascular Access (WoCoVA) being held June 20-22 in Copenhagen, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will present for the first time its expanded offerings for total vascular access management, including solutions that were acquired through its recent merger with C. R. Bard, Inc.

BD will display a comprehensive approach to vascular access management to address complications associated with peripheral and central intravenous (IV) therapy. The integrated approach combines clinical practice assessments, a comprehensive portfolio of products, and expert clinical training and education – all working together as a comprehensive offering to raise the quality of vascular access management.

With up to 50 percent of peripheral IVs in current practice not meeting their therapy goals, largely due to complicationsⁱ, it is critical to implement an integrated approach to total vascular access care to help hospitals reduce complications and improve outcomes. From failed placements to central line associated bloodstream infections (CLABSI), IV-related complications are dangerous and costly, but also preventable.

"Our expanded portfolio of solutions on display during this year's WoCoVA meeting exemplifies a significant journey in the transformation of how we provide total vascular access care that enables greater patient safety from insertion to removal and every step in between," said Ajoy Mahtab, worldwide vice president of marketing, Medication Delivery Solutions for BD. "BD is now even better positioned to address IV-related complications beyond peripheral IVs into midlines, central lines and ports with our extensive and strengthened solutions. Our comprehensive Vascular Access Management offerings will demonstrate the value of how our combined solutions can help reduce complications for patients and the process of care for health care providers."